The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
Some have expressed concern that, as PrEP use increases in the U.S., so will the transmission of other STIs. A new study pushes back against that worry.
Sexually transmitted infections are on the rise in the U.S. A recent study explored whether chlamydia and gonorrhea infections have a direct relationship to HIV rates and, if so, how large the impact is.
Our series on mentor-mentee researchers continues with Ellen Eaton, M.D., and Kelsie Dodson, with the University of Alabama at Birmingham.
If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
In an era of HIV biomedical prevention and undetectable equals untransmittable (U=U), the primacy of condom use has changed, but the need to consider approaches to decrease STIs has not.
A substudy of the high-profile French PrEP study IPERGAY has reported alarmingly high rates of human papillomavirus (HPV) infection in HIV-negative gay men.
Researchers conclude that tri-monthly STI screening including asymptomatic individuals should be considered for people with primary HIV infection, particularly in men who have sex with men who report sexual risk behavior.
To gain a better understanding of the long-term effects of STI risk among PrEP users, researchers have developed a sophisticated computer simulation that can model changes in sexual behavior, PrEP adherence, STI screening and treatment and the impact...